J Otolaryngol Ophthalmol Shandong Univ ›› 2013, Vol. 27 ›› Issue (4): 70-72.doi: 10.6040/j.issn.1673-3770.0.2013.019

• Articles • Previous Articles     Next Articles

Aspirin intolerance triad and its impact on pulmonary function and asthma control

ZHANG Tao1, ZHANG Zhi-jun1, TENG Lei1, WANG Qiong-lin2   

  1. 1. Department of Otolaryngology; 2. Department of Aspiration, Shanghai Shuguang Hospital  Affiliated with  Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2013-01-17 Published:2013-08-16

Abstract:

Objective    To investigate the impact of aspirin intolerance triad on pulmonary function and asthma clinical control. Methods    106 patients with asthma alone or with asthma in combination with allergic rhinitis or patients with aspirin intolerance triad were divided into the asthma group(n=35), the asthma combined with allergic rhinitis(AR) group(n=35) and the aspirin intolerance triad(AIT) group(n=36) at Shanghai Shuguang Hospital. Forced vital capacity(FVC), forced expiratory volume in one second(FEV1), forced expiratory volume in one second/ forced vital capacity(FEV1% FVC),peak expiratory flow(PEF), the Asthma Control Test(ACT) score and the Asthma Control Questionnaire(ACQ)score were evaluated respectively among the asthma alone group ,the asthma combined with AR group and the AIT group. Results    Patients in the AIT group had significantly(P<0.05) lower FVC, FEV1, FEV1% FVC and PEF than the asthma alone group. However patients in the AIT group had the same FVC, FEV1 and PEF as those in the asthma combined with AR group except for FEV1% FVC. The ACT score(14.2±4.5) and the ACQ score(2.7±1.5) in patients with AIT were significantly different with the asthma alone group, but were not significantly different with the asthma combined with AR group. Conclusion    AIT patients have serious airway inflammation and high airway resistance, and their lung functions and level of asthma control are bad. FEV1% FVC may be an effective and sensitive index to diagnose or evaluate AIT.

Key words: Aspirin intolerance triad, Allergic rhinitis, Pulmonary function, Asthma control questionnaire, Asthma, Asthma control test

CLC Number: 

  • R765.21
[1] WANG Tan, WU Ke, LI Lianqing, GONG Lili. Factors associated with systemic adverse reactions after subcutaneous immunotherapy injections and treatment options [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 71-74.
[2] LU Hangui, LIN Xinsheng, YAO Danmian, WEI Yongxin, LI Chuangwei. Expression of IL-35 in allergic rhinitis and its effect on the immunoregulation of T cells [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(5): 66-70.
[3] PU Hongbo, DU Xiaodong. Allergen test results in 2 000 patients with allergic rhinitis in Wuxi District [J]. J Otolaryngol Ophthalmol Shandong Univ, 2018, 32(4): 105-107.
[4] CHEN Ming, YU Xuefei. Opinions on the treatment of chronic rhinosinusitis with allergic rhinitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 18-22.
[5] WU Xiangping. Influence of patient management on the clinical effect of sublingual dermatophagoides farinae drops in patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 68-72.
[6] LIU Jie, QU Hui, LU Daowen, XIN Huaxiu, GUO Yanli. Spring pollinosis in Qingdao west district [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(2): 70-72.
[7] LI Song, WANG Zonggui, YANG Jingpu, ZHANG Zhuping. Progress of transnasal endoscopic vidian neurectomy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(1): 72-76.
[8] ZHI Lili, SONG Daoliang. Expressions of eosinophils and IL5 in antrochoanal polyps and nasal polyps. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 43-46.
[9] WAN Wenjin, WANG Wen, CHENG Lei. A meta-analysis of subcutaneous immunotherapy and sublingual immunotherapy in the treatment of dust mite-allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 103-108.
[10] ZHU Xinhua. Clinical applicationof rush immunotherapy for allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 13-17.
[11] SHI Li, ZHAO Li, ZHANG Hongping. Long-term anti-inflammatory treatment of allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 9-12.
[12] LIU Jing. Treatment of allergic rhinitis using syndrome differentiation based on the concept of “holism” in TCM. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 28-30.
[13] CHENG Lei, QIAN Junjun, TIAN Huiqin. Research progresses on allergic rhinitis. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 1-3.
[14] XU Yu, TAO Zezhang. Pharmacotherapeutic strategies for allergic rhinitis:Ithe importance of individualization and normalization. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 4-8.
[15] LI Lizhu, WU Qing, YI Xin, TIAN Li. Research progress on the animal model of allergic rhinitis in traditional Chinese medicine. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(3): 60-63.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!